Pfizer Submits Favorable Initial Data To The FDA On Kids’ COVID-19 Vaccine Trial

Posted by on September 28, 2021 8:40 am
Tags:
Categories: US National Stories

Pfizer and BioNTech say they will submit a formal request for emergency use authorization of the vaccine in young children "in the coming weeks," as they share data with the FDA about trials for kids from 5 up to 12. Here, a healthcare worker administers a dose of the vaccine to an older child at a pediatrician

Pfizer and BioNTech say they plan to submit a formal request for emergency use authorization of their vaccine in young children “in the coming weeks.”

(Image credit: Emily Elconin/Bloomberg via Getty Images)

Leave a Reply

Your email address will not be published. Required fields are marked *